CLOV vs VVOS · rev $1.37B vs rev $15.0M
Clover Health Investments Corp (CLOV) versus Vivos Therapeutics Inc (VVOS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VVOS revenue for 2024-12-31 was $15.0M. Net income was -$11.1M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. VVOS currently screens at market cap $7.1M.
CLOV currently screens at market cap $1.55B. VVOS currently screens at market cap $7.1M.
Not investment advice. Open the CLOV and VVOS stock pages for the full models.
Not investment advice.